An information leaflet for patients receiving treatment by intravitreal drug injections. Recommendations of the Expert Council on retinal and optic nerve diseases of the Association of Ophthalmologists, an All-Russian public organization

The widespread introduction of intravitreal drug injections into clinical practice has highlighted a number of issues to be solved, including the risk of serious complications, the treatment burden on patients and the patient’s insufficient adherence to treatment, as well as a significant effect on the healthcare cost and effort. One of the ways to resolve the issues is to increase the patients’ awareness concerning the therapy they are about to receive, which contributes to the patients’ understanding of the details of treatment and enables them to make correct decisions. The best option of presenting such information to the patient is to provide them with a written document. The Expert Council on Retinal and Optic Nerve Diseases of the All-Russian Association of Ophthalmologists has developed, approved and tested an information brochure for patients who receive intravitreal injections. It offers brief information on what the procedure is, contraindications, details of preparation, and symptoms, both common ones and those requiring emergency assistance. The paper outlines the results of the study and presents a layout of an information leaflet for patients recommended for use in the Russian Federation.

1. Order of the Ministry of Health of Russia 13.10.2017 №804n (red. 05.03.2020) “On the approval of the nomenclature of medical services” (in Russian). Available at: https://www.garant.ru/products/ipo/prime/doc/71705302/

2. Petri A.S., Boysen K., Cehofski L.J., et al. Intravitreal injections with Vascular Endothelial Growth Factor inhibitors: a practical approach. Ophthalmol. Ther. 2020; 9 (1): 191–203. doi: 10.1007/s40123-020-00230-4

3. Korotkikh S.A., Bobykin E.V., Ekgardt V.F., et al. Intravitreal injections in clinical practice: results of a survey of eye surgeons in the Ural federal district. Oftal'mologicheskie vedomosti. 2019; 12 (1): 27–36 (in Russian). doi: 10.17816/OV12127-36

4. Astakhov Y.S., Belekhova S.G., Litvinova E.A. Infectious and sterile endophthalmitis after intravitreal injections: differential diagnosis, prevention, treatment. Oftal'mologicheskie vedomosti. 2017; 10 (1): 62–9 (in Russian). doi: 10.17816/OV10162-69

5. Adherence to long-term therapies: evidence for action / [edited by Eduardo Sabat ]. Available at: https://apps.who.int/iris/handle/10665/42682

6. Nordmann J.P., Denis P., Vigneux M., et al. Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study. BMC Health. Serv. Res. 2007; 124 (7): 1–9. doi: 10.1186/1472-6963-7-124

7. Jandorf S., Krogh Nielsen M., S rensen K., et al. Low health literacy levels in patients with chronic retinal disease. BMC Ophthalmol. 2019; 19 (1): 174. doi: 10.1186/s12886-019-1191-1

8. Enders C., Ryszka J., Lang G.E., et al. [Patient's Knowledge after Informed Consent for Intravitreal Injections]. Klin. Monbl. Augenheilkd. 2019; 19 (Jun.). doi: 10.1055/a-0886-6507

9. Coudeyre E., Poiraudeau S., Revel M., et al. Beneficial effects of information leaflets before spinal steroid injection. Joint Bone Spine. 2002; 69: 597–603. doi: 10.1016/S1297-319X(02)00457-8

10. Rogstad K.E., Bramham L., Lowbury R., et al. Use of a leaflet to replace verbal pretest discussion for HIV: effects and acceptability. Sex Transm. Infect. 2003; 79 (3): 243–5. doi: 10.1136/sti.79.3.243

11. Turner P., Williams C. Informed consent: patients listen and read, but what information do they retain? N. Z. Med. J. 2002; 115 (1164): U218

12. Foster D.R., Rhoney D.H. Readability of printed patient information for epileptic patients. Ann. Pharmacother. 2002; 36 (12): 1856–61. doi: 10.1345/aph.1C098

13. Parahoo K., Ridley T., Thompson K., et al. A qualitative evaluation of information leaflets for gastroscopy procedure. J. Eval. Clin. Pract. 2003; 9 (4): 423–31. doi: 10.1046/j.1365-2753.2003.00397.x

14. Svarstad B.L., Bultman D.C., Mount J.K., et al. Evaluation of written prescription information provided in community pharmacies: a study in eight states. J. Am. Pharm. Assoc. 2003; 43: 383–93. doi: 10.1331/154434503321831102

15. Frost M.H., Thompson R., Thiemann K.B. Importance of format and design in print patient information. Cancer Pract. 1999; 7 (1): 22–7. doi: 10.1046/j.1523-5394.1999.07102.x

16. Harvey H.D., Fleming P. The readability and audience acceptance of printed health promotion materials used by environmental health departments. J. Environ. Health. 2003; 65 (6): 22–8. PMID:12575638

17. Patient information. Anti-VEGF intravitreal injection treatment. Moorfields Eye Hospital. Available at: https://www.moorfields.nhs.uk/sites/default/files/uploads/documents/Patient%20information%20-%20intravitreal%20injections%20for%20AMD.pdf

18. Information for patients about intravitreal injection at Mowbray Square. Available at: https://www.hdft.nhs.uk/content/uploads/2016/02/intravitreal-injection.pdf

19. Intravitreal Injections — The American Society of Retina Specialists. Available at: https://www.asrs.org/patients/retinal-diseases/33/intravitreal-injections

20. Patient Information: Intravitreal Injection. Retina Eye Specialists. Available at: http://www.retinaeye.com/common%20diseases/Uveitis/Intravitreal%20Injection%20patient%20handout.pdf

21. Patient Information Leaflet. Treatment of Wet Macular Degeneration with Intravitreal Injections of Anti-VEGF Drugs. Available at: https://www.eyedoctors.ie/medium/files/Wet%20AMD%20Patient%20Information%20Leaflet%20Clear%20Print.pdf

22. Intravitreal Injections. Patient Education by University of Michigan Health System. Available at: http://www.med.umich.edu/1libr/Ophthalmology/OcularOncology/IntravitrealInjections.pdf

23. Intravitreal Injection Patient Information Leaflet — Royal Victoria Eye and Ear Hospital. Available at: https://www.rveeh.ie/app/uploads/2017/04/intravitreal_injection_patient_information_leaflet.pdf

24. Neroev V.V., Astakhov Yu.S., Korotkih S.A., et al. Protocol of intravitreal drug delivery. Consensus of the Expert Council of Retina and Optic Nerve Diseases of the All-Russian Public Organization “Association of Ophthalmologists”. Vestnik oftal’mologii. 2020; 136 (6): 251–63 (in Russian). doi: 10.17116/oftalma2020136062251

25. NHS Toolkit for producing patient information. Available at: https://www.uea.ac.uk/documents/746480/2855738/Toolkit_for_producing_patient_information.pdf

26. Brown H., Ramchandani M., Gillow J.T., et al. Are patient information leaflets contributing to informed consent for cataract surgery? J. Med. Ethics. 2004; 30 (2): 218–20. doi: 10.1136/jme.2003.003723

27. DISCERN instrument and handbook (online version). Available at: http://www.discern.org.uk/

28. Rajasundaram R., Phillips S., Clay N.R. Information leaflet used in out-patient clinics: a survey of attitude and understanding of the user. Int. J. Health Care Qual. Assur. Inc. Leaders’ Health Serv. 2006; 19 (6-7): 575–9. doi: 10.1108/09526860610704196

29. Checking the readability of texts — PlainRussian.ru (in Russian). Available at: http://ru.readability.io/

30. Neroev V.V., Zaytseva O.V., Bobykin E.V., et al. Results of clinical approbation of information leaflet for patients treated with intravitreal injections of drugs. Russian ophthalmological journal. 2021; 14 (2 Supplement): 20–8 (in Russian). https://doi.org/10.21516/2072-0076-2021-14-2-supplement-20-28

31. The original layout of the leaflet “Intravitreal injections (information for patients)” (in Russian). Available at: http://avo-portal.ru/forpatients